Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.59 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 5/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11119930 | 0.89 | GABRA1 (0.59) | GABRA1GABRB2CA2AKR1B1GAA | |
| 2-Allylphenol SCHEMBL9516154 | 0.87 | CA2 (0.53) | GABRA1GABRB2CA2AKR1B1GAA | |
| SCHEMBL10554307 | 0.83 | CA2 (0.52) | GABRA1GABRB2CA2GAAALOX12 | |
| SCHEMBL6841870 | 0.81 | GABRA1 (0.42) | GABRA1GABRB2CA2ALDH1A1LMNA | |
| SCHEMBL9195190 | 0.81 | AKR1B1 (0.60) | GABRA1GABRB2CA2AKR1B1GAA | |
| SCHEMBL168974 | 0.80 | GABRA1 (0.79) | GABRA1GABRB2AKR1B1GAAALOX12 | |
| SCHEMBL27775371 | 0.80 | GABRA1 (0.43) | GABRA1GABRB2CA2AKR1B1GAA | |
| SCHEMBL10413004 | 0.80 | GABRA1 (0.43) | GABRA1GABRB2CA2AKR1B1GAA | |
| SCHEMBL8850517 | 0.79 | GABRA1 (0.68) | GABRA1GABRB2AKR1B1GAAMEN1 | |
| 2-Allylphenol SCHEMBL10901820 | 0.79 | TSHR (0.60) | GABRA1GABRB2CA2AKR1B1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0593497-A1 | PROCESS FOR THE PREPARATION OF 2-ALKYL-4-ACYL-6--i(TERT)-BUTYLPHENOL COMPOUNDS. | PROCTER & GAMBLE (US) | 1994-04-27 | — | — | EP | claimed |
| WO-1992017432-A1 | PROCESS FOR THE PREPARATION OF 2-ALKYL-4-ACYL-6-TERT-BUTYLPHENOL COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 1992-10-15 | — | — | WO | claimed |
| US-5126487-A | Reacting 2-alkyl-6-tert-butyl phenol, unsaturated carboxylic acid, trifluoroacetic anhydride | THE PROCTER & GAMBLE COMPANY (US) | 1992-06-30 | — | — | US | claimed |
| US-4219570-A | Insect repellents and a method of repelling insects | AJINOMOTO COMPANY, INCORPORATED (JP) | 1980-08-26 | — | — | US | claimed |
| JP-59053469-A | — | — | None | — | — | JP | disclosed |
| EP-2334624-B1 | PROCESS FOR MAKING 2-SECONDARY-ALKYL-4,5-DI-(NORMAL-ALKYL)PHENOLS | INVISTA TECHNOLOGIES SRL (CH) | 2014-10-01 | — | — | EP | disclosed |
| US-8247621-B2 | Process for making 2-secondary-alkyl-4,5-di-(normal-alkyl)phenols | INVISTA NORTH AMERICA S.A.R.L. (US) | 2012-08-21 | — | — | US | disclosed |
| EP-2334624-A1 | PROCESS FOR MAKING 2-SECONDARY-ALKYL-4,5-DI-(NORMAL-ALKYL)PHENOLS | Invista Technologies S.A R.L. (CH) | 2011-06-22 | — | — | EP | disclosed |
| WO-2010045131-A1 | PROCESS FOR MAKING 2-SECONDARY-ALKYL-4,5-DI-(NORMAL-ALKYL)PHENOLS | INVISTA TECHNOLOGIES S.A.R.L. (CH) | 2010-04-22 | — | — | WO | disclosed |
| US-20100099922-A1 | PROCESS FOR MAKING 2-SECONDARY-ALKYL-4,5-DI-(NORMAL-ALKYL)PHENOLS | INVISTA NORTH AMERICA S.A.R.L. (US) | 2010-04-22 | — | — | US | disclosed |
| US-20090082434-A1 | Dihydrobenzofuranyl Alkanamine Derivatives and Methods for Using Same | WYETH (US) | 2009-03-26 | — | — | US | disclosed |
| US-7435837-B2 | Dihydrobenzofuranyl alkanamine derivatives and methods for using same | WYETH (US) | 2008-10-14 | — | — | US | disclosed |
| US-4847303-A | UNSATURATED KETONES | THE PROCTER & GAMBLE COMPANY (US) | 1989-07-11 | — | — | US | disclosed |
| EP-0321432-A1 | Process for the preparation of certain substituted aromatic compounds | Norwich Eaton Pharmaceuticals, Inc. (US) | 1989-06-21 | — | — | EP | disclosed |
| EP-0292660-A2 | Alkylidenedithiobis (substituted) phenols for inhibiting interleukin-1 release and for alleviating interleukin-1 mediated conditions | MERRELL DOW PHARMACEUTICALS INC. (US) | 1988-11-30 | — | — | EP | disclosed |
| EP-0117328-B1 | LIQUID FUELS CONTAINING CORROSION INHIBITORS, AND INHIBITOR CONCENTRATES | ETHYL PETROLEUM ADDITIVES LIMITED (GB) | 1987-04-29 | — | — | EP | disclosed |
| EP-0117328-A1 | Liquid fuels containing corrosion inhibitors, and inhibitor concentrates | ETHYL PETROLEUM ADDITIVES LIMITED (GB) | 1984-09-05 | — | — | EP | disclosed |
| JP-S5953469-A | PREPARATION OF BENZIMIDAZOLINE-2-THIONE DERIVATIVE | SUMITOMO CHEM CO LTD | 1984-03-28 | — | — | JP | disclosed |
| US-4236032-A | FROM 3-ALKYLPHENOLS OR 2,3-DIALKYLPHENOLS | CONOCO, INC. (US) | 1980-11-25 | — | — | US | disclosed |
| US-4236032-A | FROM 3-ALKYLPHENOLS OR 2,3-DIALKYLPHENOLS | CONOCO, INC. (US) | 1980-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090082434-A1 | Dihydrobenzofuranyl Alkanamine Derivatives and Methods for Using Same | HTR2C, HTR1A, HTR3A | GABRA1 123/4885GABRB2 184/4885CA2 2818/4885 |
| US-20100099922-A1 | PROCESS FOR MAKING 2-SECONDARY-ALKYL-4,5-DI-(NORMAL-ALKYL)PHENOLS | UGT1A4, CYP4B1, CYP4X1 | GABRA1 4084/4885GABRB2 3781/4885CA2 3450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.